EUCTR2006-003302-25-GB进行中（未招募）1 期
A prospective, randomised, double-blind, placebo-controlled trial to assess the respiratory effects of oxycodone versus morphine in anaesthetised patients - randomised, double-blind, placebo-controlled,respiratory effects, oxycodone, morphine
Barts and The London NHS Trust0 个研究点目标入组 0 人开始时间: 2006年10月9日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •Patients aged 18-55 years.
- •Patients who are American Society of Anesthesiologists (ASA) Scores of I or II.(Generally fit and well, with no uncontrolled medical problems)
- •They must be inpatients in hospital.
- •Patients who are due to undergo surgery of greater than 30 minutes duration under general anaesthesia.
- •Patients who weigh between 45kg and 100kg and/or a Body Mass Index of less than 30.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Patients undergoing emergency surgery.
- •Patients who are allergic to oxycodone, naloxone or morphine.
- •Patients with a history of substance abuse.
- •Patients who have been on long-term opioid therapy, or have taken strong opioids within the last two weeks.
- •Patients who are considered unsuitable by the responsible anaesthetist for whom lengthening of the anaesthetic time is deemed to constitute an unaccetable, increased risk.
- •Patients who have any conidtion predisposing them to respiratory depression.
- •Patients who are involved in existing research.
研究者
相似试验
进行中（未招募）
1 期
A prospective, randomised, double-blind, placebo-controlled, parallel group dose ranging study in asthma patients in Iceland to assess the safety, tolerability and efficacy of the MLK inhibitor, CEP-1347AsthmaEUCTR2004-002812-27-ISdeCODE genetics ehf.160
已完成
不适用
A prospective, randomised, double-blind, placebo-controlled trial evaluating the effects of mycophenolate mofetil (MMF) on surrogate markers for atherosclerosis in female patients with systemic lupus erythematosusMusculoskeletal DiseasesSystemic lupus erythematosusISRCTN57744970Guy's and St Thomas' NHS Foundation Trust (UK)100
已完成
不适用
A prospective, randomised, double-blind, placebo-controlled trial to assess the respiratory effects of oxycodone versus morphine in anaesthetised patientsISRCTN30198912Record Provided by the NHSTCT Register - 2007 Update - Department of Health60
进行中（未招募）
不适用
A prospective, randomised, double-blind, placebo-controlled, parallel-group, international multicentre phase III trial of PI-88 in the adjuvant treatment of post-resection hepatocellular carcinomaEstudio Fase III, internacional, multicéntrico, prospectivo, aleatorizado, doble-ciego y controlado con placebo, de grupos paralelos de PI-88 en el tratamiento adyuvante de carcinoma hepatocelular post-resección (Pathway) - PATHWAYpost-resection hepatocellular carcinomaCarcinoma hepatocelular post-resecciónMedDRA version: 9.1Level: LLTClassification code 10019830Term: Hepatocellular carcinoma resectableEUCTR2007-005011-25-ESProgen Pharmaceuticals Limited600
进行中（未招募）
1 期
A prospective, double-blind, randomised, placebo-controlled trial on the efficacy and safety of Neiromidin 20 mg tablets in the treatment of patients with lumbosacral radiculopathyumbosacral radiculopathyEUCTR2019-002632-90-PLOlainfarm AS458